Klaus Richter

Title: Klaus Richter: Innovator in Biotechnology

Introduction

Klaus Richter is a notable inventor based in Salzburg, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and nucleic acids. With a total of 2 patents, his work has implications in both diagnosis and therapy.

Latest Patents

Richter's latest patents include a groundbreaking invention related to nucleic acid sequences and proteins, specifically polypeptides coding for mannitol dehydrogenases. This invention focuses on the production and use of these polypeptides in medical diagnostics and therapeutic applications. Another significant patent involves DNA molecules that code for the allergen Art v 1 and its isoforms. This patent outlines the sequence of the allergen, methods for producing an Art v 1 molecule, and the development of vectors and transformed host cells.

Career Highlights

Throughout his career, Klaus Richter has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Biomay Produktions- und Handelsaktiengesellschaft and Biomay AG. His work in these organizations has allowed him to advance his research and contribute to innovative solutions in biotechnology.

Collaborations

Richter has collaborated with esteemed colleagues, including Christof Ebner and Michael Breitenbach. These partnerships have fostered a collaborative environment that enhances the development of innovative biotechnological solutions.

Conclusion

Klaus Richter's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical diagnostics and therapies.